These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11454102)

  • 1. The effect of enalapril and verapamil on the left ventricular hypertrophy and the left ventricular cardiomyocyte numerical density in rats submitted to nitric oxide inhibition.
    Pereira LM; Mandarim-De-Lacerda CA
    Int J Exp Pathol; 2001 Apr; 82(2):115-22. PubMed ID: 11454102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereology of cardiac hypertrophy induced by NO blockade in rats treated with enalapril and verapamil.
    Pereira LM; Mandarim-de-Lacerda CA
    Anal Quant Cytol Histol; 2001 Oct; 23(5):330-8. PubMed ID: 11693558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Volume-weighted mean nuclear volume and numerical nuclear density in the cardiomyocyte following enalapril and verapamil treatment.
    Mandarim-de-Lacerda CA; Pereira LM
    Virchows Arch; 2001 Jan; 438(1):92-5. PubMed ID: 11213841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of antihypertensive drugs on the myocardial microvessels in rats with nitric oxide blockade.
    Meirelles Pereira LM; Mandarim-de-Lacerda CA
    Pathol Res Pract; 2000; 196(5):305-11. PubMed ID: 10834387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal cortical remodelling by NO-synthesis blockers in rats is prevented by angiotensin-converting enzyme inhibitor and calcium channel blocker.
    Mandarim-de-Lacerda CA; Pereira LM
    J Cell Mol Med; 2001; 5(3):276-83. PubMed ID: 12067486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aortic wall remodeling in rats with nitric oxide deficiency treated by enalapril or verapamil.
    Pereira LM; Bezerra DG; Mandarim-de-Lacerda CA
    Pathol Res Pract; 2004; 200(3):211-7. PubMed ID: 15200273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart biometry and allometry in rats submitted to nitric oxide synthesis blockade and treatment with antihypertensive drugs.
    Mandarim-de-Lacerda CA; Pereira LM
    Ann Anat; 2001 Mar; 183(2):171-6. PubMed ID: 11325065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic inhibition of nitric oxide synthase induces hypertension and cardiomyocyte mitochondrial and myocardial collagen remodelling in the absence of hypertrophy.
    Rossi MA; Ramos SG; Prado CM
    J Hypertens; 2003 May; 21(5):993-1001. PubMed ID: 12714875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enalapril attenuates cardiorenal damage in nitric-oxide-deficient spontaneously hypertensive rats.
    Pereira LM; Bezerra DG; Machado DL; Mandarim-de-Lacerda CA
    Clin Sci (Lond); 2004 Mar; 106(3):337-43. PubMed ID: 14629192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basilar artery remodelling in the genetically hypertensive rat: effects of nitric oxide synthase inhibition and treatment with valsartan and enalapril.
    Ledingham JM; Laverty R
    Clin Exp Pharmacol Physiol; 2000 Aug; 27(8):642-6. PubMed ID: 10901398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Captopril prevents NO-deficient hypertension and left ventricular hypertrophy without affecting nitric oxide synthase activity in rats.
    Bernátová I; Pechánová O; Simko F
    Physiol Res; 1996; 45(4):311-6. PubMed ID: 9085355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effect of enalapril in spontaneously hypertensive rats cardiac remodeling with nitric oxide synthesis blockade.
    de Andrade Zorzi RL; Meirelles Pereira LM; Mandarim-de-Lacerda CA
    J Cell Mol Med; 2002; 6(4):599-608. PubMed ID: 12611644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term ACE inhibition confers long-term protection against target organ damage.
    Hale TM; Robertson SJ; Burns KD; deBlois D
    Hypertens Res; 2012 Jun; 35(6):604-10. PubMed ID: 22318205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of left ventricular hypertrophy in hypertensive patients with a combination of verapamil and captopril--a multicenter study.
    Magometschnigg D; Brandt D; Hofmann R; Sihorsch K; Stoschitzky K; Zangeneh M; Zenker G
    Int J Clin Pharmacol Ther; 1997 Sep; 35(9):389-96. PubMed ID: 9314093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitric oxide-deficiency-induced hypertension in rats.
    García-Estañ J; Ortiz MC; O'Valle F; Alcaraz A; Navarro EG; Vargas F; Evangelista S; Atucha NM
    Clin Sci (Lond); 2006 Feb; 110(2):227-33. PubMed ID: 16197366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the inhibitory effect of N(G)-nitro-L-arginine methyl ester on the antihypertensive effect of the angiotensin AT1 receptor antagonist, GR138950.
    Anderson IK; Drew GM
    Br J Pharmacol; 1997 Dec; 122(7):1385-94. PubMed ID: 9421286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of cardiomyocyte hypotrophy in rats under prolonged treatment with a low dose of a nitric oxide synthesis inhibitor.
    de Oliveira CF; Cintra KA; Teixeira SA; De Luca IM; Antunes E; De Nucci G
    Eur J Pharmacol; 2000 Mar; 391(1-2):121-6. PubMed ID: 10720643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kidney adaptation in nitric oxide-deficient Wistar and spontaneously hypertensive rats.
    Pereira LM; Almeida JR; Mandarim-de-Lacerda CA
    Life Sci; 2004 Jan; 74(11):1375-86. PubMed ID: 14706568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuation of hypertension, cardiomyocyte hypertrophy, and myocardial fibrosis by beta-adrenoceptor blockers in rats under long-term blockade of nitric oxide synthesis.
    Pacca SR; de Azevedo AP; De Oliveira CF; De Luca IM; De Nucci G; Antunes E
    J Cardiovasc Pharmacol; 2002 Feb; 39(2):201-7. PubMed ID: 11791005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of interstitial fibroblast hyperplasia via apoptosis in hypertensive rat heart with valsartan or enalapril.
    Der Sarkissian S; Marchand EL; Duguay D; Hamet P; deBlois D
    Cardiovasc Res; 2003 Mar; 57(3):775-83. PubMed ID: 12618239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.